[PDF] Top 20 <p>Treatment of central serous chorioretinopathy with topical NSAIDs</p>

... with topical NSAIDs had a signi fi cantly faster resolution of subretinal fl ...the treatment and control groups, the difference is not statistically signi fi cant owing to a small sample ...starting ... See full document

... prior treatment failures with various oral and invasive modalities (such as laser and injections) allude to the chronic and recurrent nature that this cohort ... See full document

... Retrospective data were collected on the patient’s first presen- tation, based on available multimodal imaging (at least FA and OCT). This information was used to distinguish between an acute and a chronic first ... See full document

... Briefly, omeprazole (20 mg), clarithromycin (500 mg), and amoxicillin (1,000 mg) were orally administered twice a day after meals for 14 days. The control group received an identi- cal placebo that was the same color, ... See full document

... Our study was too small to draw conclusions from subgroups but similar predictive factors as in anti-VEGF monotherapy may play a role. Kim et al identified clinical characteristics for good responders to intravitreal ... See full document

... μm; p = ...of treatment as compared to the baseline (Table ...of treatment are also presented in Table 3. EDI-OCT scans and central macular thickness measures in a representative CSCR patient ... See full document

... previous treatment with thermal laser or PDT; (2) history of intraocular surgery within the last 6 months; (3) chorioretinal diseases like age-related macular degeneration, polypoidal choroidal vasculopathy, high ... See full document

... acute central serous chorioretinopathy by focal photocoagulation of leaking retinal pigment epithelium lesions, and in chronic central serous chorioretinopathy by photodynamic ... See full document

... unilateral central serous chorioretinopathy (CSC) and compare them with their non-affected eye and with a control ...laser treatment, there were only nonsignificant differences of both ... See full document

... Treatment planning was done using the earliest phase of FFA on Navilas system that showed the leaking spot. Initially, the power of 577 nm yellow laser was titrated to just produce a mild retinal whitening outside ... See full document

... other treatment modalities. BCVA gain in the treatment of chronic CSCR with photodynamic therapy (PDT) is similar to SMPLT, usu- ally at the level of a few ETDRS letters or 1 Snellen line ...the ... See full document

... require treatment with ophthalmological surveillance. Treatment, however, is occasionally necessary in patients with ...for treatment include persistence of a serous retinal detachment for ... See full document

... Subthreshold green laser (532 nm) is a safe and effective modality for the treatment of chronic CSCR with very good and stable outcomes. It may also be beneficial in the treat- ment of PEDs. The results are ... See full document

... leaking spot. The same physician performed the laser treat- ment on the same device without using contact lens. Initial test burn was performed away from the macular region to decide the parameters for treatment ... See full document

... increasing the power by increments of 10 mW, moving to a new area each time, until a barely visible reaction was seen. After that, the mode was switched to micropulse and the power used in the treatment was triple ... See full document

... undergoing treatment (Group A), was compared with an historic control group consisting of patients with either classic or multifocal CSCR identified from the files of the Retina Service from June 2001 to December ... See full document

... PDT treatment was ...after treatment. Post-treatment optical coherence tomography (OCT) studies demonstrated complete resolution of the PED in 60% of eyes with incomplete resolution in the remaining ... See full document

... the treatment of chronic and atypical or excessive CSC when retinal detachment is excessive and leaking points are ...TTT treatment of subfoveal neovascularization in AMD, vision is either maintained or ... See full document

... CSCR is a challenging disease to understand and treat, since its pathogenesis remains elusive and multifacto- rial. Systemic emerging pharmacologic approaches, like eplerenone, are intriguing, as they target several ... See full document

... the treatment group and the control group. SRF height, central macular thickness and lesion size in each group improved signi fi cantly from baseline to 6-month ...the treatment group than the control ... See full document